Evidence map›Paper›PMID 36630820›Full record

ArticleRedox biology2023

Targeting succinate metabolism to decrease brain injury upon mechanical thrombectomy treatment of ischemic stroke.

Amin Mottahedin, Hiran A Prag, Andreas Dannhorn, Richard Mair, Christina Schmidt, Ming Yang, Annabel Sorby-Adams, Jordan J Lee, Nils Burger, Duvaraka Kulaveerasingam and 7 more

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. PreclinicalMagnetic resonance in medicine · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. [Role of succinylation modification in central nervous system diseases].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Review
  9. Article
  10. Article
  11. From Mechanisms to Diseases: The Succinate-GPR91 Axis in Cardiometabolic Diseases.Journal of cardiovascular translational research · 2025
    Review
  12. Rescuing Ischemic Brain Injury by Rewiring Mitochondrial Electron Flow.bioRxiv : the preprint server for biology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 3 countries.

Amin MottahedinMRC Mitochondrial Biology Unit, University of Cambridge, The Keith Peters Building, Cambridge Biomedical Campus, Cambridge, UK; Department of Physiology, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden. Electronic address: amin.mottahedin@ndcn.ox.ac.uk.
Hiran A PragDepartment of Medicine, University of Cambridge, Cambridge University Hospitals, Cambridge, UK.
Andreas DannhornImaging and Data Analytics, Clinical Pharmacology and Safety Sciences, R & D, AstraZeneca, Cambridge, UK.
Richard MairDivision of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK.
Christina SchmidtCECAD Research Center, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.
Ming YangCECAD Research Center, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.
Annabel Sorby-AdamsMRC Mitochondrial Biology Unit, University of Cambridge, The Keith Peters Building, Cambridge Biomedical Campus, Cambridge, UK.
Jordan J LeeDepartment of Medicine, University of Cambridge, Cambridge University Hospitals, Cambridge, UK.
Nils BurgerMRC Mitochondrial Biology Unit, University of Cambridge, The Keith Peters Building, Cambridge Biomedical Campus, Cambridge, UK.
Duvaraka KulaveerasingamDepartment of Medicine, University of Cambridge, Cambridge University Hospitals, Cambridge, UK.
Margaret M HuangMRC Mitochondrial Biology Unit, University of Cambridge, The Keith Peters Building, Cambridge Biomedical Campus, Cambridge, UK.
Stefano PluchinoDepartment of Clinical Neurosciences and NIHR Biomedical Research Centre, University of Cambridge, UK.
Luca Peruzzotti-JamettiDepartment of Clinical Neurosciences and NIHR Biomedical Research Centre, University of Cambridge, UK.
Richard GoodwinImaging and Data Analytics, Clinical Pharmacology and Safety Sciences, R & D, AstraZeneca, Cambridge, UK.
Christian FrezzaCECAD Research Center, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.
Michael P MurphyMRC Mitochondrial Biology Unit, University of Cambridge, The Keith Peters Building, Cambridge Biomedical Campus, Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge University Hospitals, Cambridge, UK. Electronic address: mpm@mrc-mbu.cam.ac.uk.
Thomas KriegDepartment of Medicine, University of Cambridge, Cambridge University Hospitals, Cambridge, UK. Electronic address: tk382@medschl.cam.ac.uk.
University of Cambridge · GBCologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases · DEAstraZeneca (United Kingdom) · GBMRC Mitochondrial Biology Unit · GB

Funding

Cancer Research UK C51061/A27453Medical Research Council MC_UU_00028/4Medical Research Council MC_UU_12022/6Medical Research Council MRC_MC_UU_12022/6Wellcome Trust 220257/Z/20/ZWellcome Trust G105713
6 · The paper itself

Abstract

Current treatments for acute ischemic stroke aim to reinstate a normal perfusion in the ischemic territory but can also cause significant ischemia-reperfusion (IR) injury. Previous data in experimental models of stroke show that ischemia leads to the accumulation of succinate, and, upon reperfusion, the accumulated succinate is rapidly oxidized by succinate dehydrogenase (SDH) to drive superoxide production at mitochondrial complex I. Despite this process initiating IR injury and causing further tissue damage, the potential of targeting succinate metabolism to minimize IR injury remains unexplored. Using both quantitative and untargeted high-resolution metabolomics, we show a time-dependent accumulation of succinate in both human and mouse brain exposed to ischemia ex vivo. In a mouse model of ischemic stroke/mechanical thrombectomy mass spectrometry imaging (MSI) shows that succinate accumulation is confined to the ischemic region, and that the accumulated succinate is rapidly oxidized upon reperfusion. Targeting succinate oxidation by systemic infusion of the SDH inhibitor malonate upon reperfusion leads to a dose-dependent decrease in acute brain injury. Together these findings support targeting succinate metabolism upon reperfusion to decrease IR injury as a valuable adjunct to mechanical thrombectomy in ischemic stroke.

Indexed as

Brain InjuriesBrain IschemiaIschemic StrokeReperfusion InjuryStrokeAnimalsHumansIschemiaMiceSuccinic AcidThrombectomySuccinic Acid

Identifiers

PMID36630820
PMCPMC9841348
OpenAlexW4313427067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.